Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$53.56 USD

53.56
374,454

-1.24 (-2.26%)

Updated May 3, 2024 04:00 PM ET

After-Market: $53.62 +0.06 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.

Linde's (LIN) Q1 Earnings Beat Estimates on Higher Pricing

by Zacks Equity Research

Higher pricing from the Americas segment aids Linde's (LIN) Q1 earnings, offset partially by lower contributions from the Engineering business unit.

Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 40.54% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Wil Higher Uranium Prices Aid Energy Fuels' (UUUU) Q1 Earnings?

by Zacks Equity Research

Energy Fuels' (UUUU) first-quarter 2024 results are likely to reflect increased uranium sales, as the company is expected to have capitalized on the elevated prices witnessed throughout the quarter.

Olin's (OLN) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

Olin's (OLN) first-quarter earnings and sales surpass the respective estimates as strong Winchester results offset the weakness in its Chemical businesses.

Air Products (APD) Earnings Beat, Revenues Miss Estimates in Q2

by Zacks Equity Research

Air Products' (APD) fiscal second-quarter earnings surpass estimates while sales miss the same due to lower volumes.

Albemarle (ALB) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost and productivity actions in the first quarter amid headwinds from softer lithium market prices.

Will Lower Production Weigh on Barrick's (GOLD) Q1 Earnings?

by Zacks Equity Research

Lower gold production and higher costs are likely to have affected Barrick's (GOLD) Q1 performance.

WestRock (WRK) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

WestRock's (WRK) Q2 results are likely to reflect lower volumes due to muted customer spending.

Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Mosaic's (MOS) Q1 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.

DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?

by Zacks Equity Research

DuPont (DD) is expected to have benefited from its innovation-driven investment and pricing and productivity actions in the first quarter amid demand headwinds.

Analysts Estimate AdvanSix (ASIX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

AdvanSix (ASIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LyondellBasell (LYB) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

LyondellBasell's (LYB) first-quarter results are likely to be affected by weaker demand amid economic uncertainties.

Ingevity (NGVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

by Zacks Equity Research

Ingevity (NGVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity (NGVT) Up 0.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ingevity's (NGVT) Earnings and Sales Surpass Estimates in Q4

by Zacks Equity Research

Ingevity (NGVT) sees strong results in the Performance Materials segment and the Road Technologies business line in Q4.

Ingevity (NGVT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Ingevity (NGVT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Ingevity (NGVT) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 261.54% and 12.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Wall Street's Insights Into Key Metrics Ahead of Ingevity (NGVT) Q4 Earnings

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Ingevity (NGVT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Green Plains Renewable Energy (GPRE) Q4 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Green Plains (GPRE) delivered earnings and revenue surprises of -25% and 13.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ingevity (NGVT) Extends Distributorship With TRiiSO for Capa

by Zacks Equity Research

TRiiSO's technical support strengths complement Ingevity's (NGVT) commitment to providing solutions to challenging formulation issues.

Ingevity's (NGVT) Earnings and Sales Miss Estimates in Q3

by Zacks Equity Research

Lower volumes due to weak industrial demand hurt Ingevity's (NGVT) Advanced Polymer Technologies and the Industrial Specialties business lines in Q3.

Compared to Estimates, Ingevity (NGVT) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.